West Pharmaceutical Services Inc. (WST): Price and Financial Metrics
WST Price/Volume Stats
| Current price | $385.73 | 52-week high | $415.73 |
| Prev. close | $390.20 | 52-week low | $310.42 |
| Day low | $385.45 | Volume | 757,200 |
| Day high | $394.42 | Avg. volume | 512,228 |
| 50-day MA | $378.30 | Dividend yield | 0.22% |
| 200-day MA | $371.38 | Market Cap | 28.24B |
WST Stock Price Chart Interactive Chart >
West Pharmaceutical Services Inc. (WST) Company Bio
West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. Founded in 1923 by Herman O. West and J.R. Wike of Philadelphia, the company is headquartered in Exton, Pennsylvania. In its early years of development, West produced rubber components for packaging injectable drugs, providing a sterile environment for the producers of penicillin and insulin. (Source:Wikipedia)
Latest WST News From Around the Web
Below are the latest news stories about WEST PHARMACEUTICAL SERVICES INC that investors may wish to consider to help them evaluate WST as an investment opportunity.
MMSI or WST: Which Is the Better Value Stock Right Now?MMSI vs. WST: Which Stock Is the Better Value Option? |
West Announces First-Quarter 2024 DividendWest Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a first-quarter 2024 dividend of $0.20 per share. The dividend will be paid on February 7, 2024, to shareholders of record as of January 31, 2024. |
West Pharmaceutical's (WST) New Launch to Expand PortfolioWest Pharmaceutical's (WST) latest addition to its portfolio is likely to address the critical need for more drug preparation and delivery options at the point of care. |
West Receives FDA 510(k) Clearance for Vial2Bag Advanced® 13mm Admixture DeviceWest Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration systems, today announced FDA 510(k) clearance and launch of its Vial2Bag Advanced® 13mm admixture device. |
Reasons to Retain West Pharmaceutical (WST) in Your PortfolioWest Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist. |
WST Price Returns
| 1-mo | -0.59% |
| 3-mo | 6.86% |
| 6-mo | 20.40% |
| 1-year | 8.21% |
| 3-year | 20.45% |
| 5-year | 216.06% |
| YTD | 9.66% |
| 2023 | 49.97% |
| 2022 | -49.70% |
| 2021 | 65.88% |
| 2020 | 89.05% |
| 2019 | 54.13% |
WST Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Continue Researching WST
Want to do more research on West Pharmaceutical Services Inc's stock and its price? Try the links below:West Pharmaceutical Services Inc (WST) Stock Price | Nasdaq
West Pharmaceutical Services Inc (WST) Stock Quote, History and News - Yahoo Finance
West Pharmaceutical Services Inc (WST) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...